NCT04215640View on ClinicalTrials.gov

Radiofrequency Ablation of Paroxysmal Supraventricular Tachycardia Using a Novel Catheter Equipped With Mini Electrodes

NACompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

January 13, 2020

Primary Completion Date

November 1, 2021

Study Completion Date

November 1, 2021

Conditions
Paroxysmal Supraventricular Tachycardia
Interventions
DEVICE

Microfidelity (MIFI) catheter

Patients are randomized into the MIFI group and control group. Radiofrequency ablation will target slow pathway for AVNRT or accessory pathway for AVRT. Microfidelity (MIFI) catheter equipped with mini-electrodes will be used for ablation in the MIFI group.

DEVICE

Conventional ablation catheter

Patients are randomized into the MIFI group and control group. Radiofrequency ablation will target slow pathway for AVNRT or accessory pathway for AVRT. Blazer II radiofrequency ablation catheter will be used for ablation in the control group.

Trial Locations (1)

137-701

Seoul St Mary's Hospital, Seoul

All Listed Sponsors
lead

Yong Seog Oh

OTHER

NCT04215640 - Radiofrequency Ablation of Paroxysmal Supraventricular Tachycardia Using a Novel Catheter Equipped With Mini Electrodes | Biotech Hunter | Biotech Hunter